Targeting 5-HT1A receptors in astrocytes to protect dopaminergic neurons in parkinsonian models

Ikuko Miyazaki, Masato Asanuma, Shinki Murakami, Mika Takeshima, Nao Torigoe, Yoshihisa Kitamura, Ko Miyoshi

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Astrocytes are abundant neuron-supporting glial cells that harbor a powerful arsenal of neuroprotective antioxidative molecules and neurotrophic factors. Here we examined whether enrichment with healthy striatal astrocytes can provide neuroprotection against progressive dopaminergic neurodegeneration. Serotonin 1A (5-HT1A) agonist 8-OH-DPAT induced astrocyte proliferation and increased metallothionein-1/-2 (MT-1/-2), antioxidative molecules, in cultured astrocytes and the striatum of mice. Primary cultured mesencephalic dopamine neurons were protected against oxidative stress by preincubation with conditioned media from 8-OH-DPAT-treated astrocytes. These protective effects were canceled by 5-HT1A antagonist or MT-1/-2-specific antibody. Furthermore, reduction of nigrostriatal dopaminergic neurons in 6-hydroxydopamine-lesioned parkinsonian model mice was significantly abrogated by repeated injections of 8-OH-DPAT. Treatment with 8-OH-DPAT markedly increased the expression of MT in striatal astrocytes in the hemi-parkinsonian mice. Our study provides a promising therapeutic strategy of neuroprotection against oxidative stress and progressive dopaminergic neurodegeneration by demonstrating the efficacy of targeting 5-HT1A receptors in astrocytes.

Original languageEnglish
Pages (from-to)244-256
Number of pages13
JournalNeurobiology of Disease
Volume59
DOIs
Publication statusPublished - Nov 2013

Fingerprint

Receptor, Serotonin, 5-HT1A
Dopaminergic Neurons
Astrocytes
8-Hydroxy-2-(di-n-propylamino)tetralin
Corpus Striatum
Metallothionein
Oxidative Stress
Serotonin 5-HT1 Receptor Antagonists
Serotonin 5-HT1 Receptor Agonists
Oxidopamine
Nerve Growth Factors
Conditioned Culture Medium
Neuroglia
Serotonin
Neurons
Injections
hydroxide ion
Antibodies
Therapeutics

Keywords

  • 5-HT receptor
  • 8-OH-DPAT
  • Astrocyte
  • Metallothionein
  • Neuroprotection
  • Parkinson's disease

ASJC Scopus subject areas

  • Neurology

Cite this

Targeting 5-HT1A receptors in astrocytes to protect dopaminergic neurons in parkinsonian models. / Miyazaki, Ikuko; Asanuma, Masato; Murakami, Shinki; Takeshima, Mika; Torigoe, Nao; Kitamura, Yoshihisa; Miyoshi, Ko.

In: Neurobiology of Disease, Vol. 59, 11.2013, p. 244-256.

Research output: Contribution to journalArticle

@article{a5362c6f02c54e69b7b28d586681d657,
title = "Targeting 5-HT1A receptors in astrocytes to protect dopaminergic neurons in parkinsonian models",
abstract = "Astrocytes are abundant neuron-supporting glial cells that harbor a powerful arsenal of neuroprotective antioxidative molecules and neurotrophic factors. Here we examined whether enrichment with healthy striatal astrocytes can provide neuroprotection against progressive dopaminergic neurodegeneration. Serotonin 1A (5-HT1A) agonist 8-OH-DPAT induced astrocyte proliferation and increased metallothionein-1/-2 (MT-1/-2), antioxidative molecules, in cultured astrocytes and the striatum of mice. Primary cultured mesencephalic dopamine neurons were protected against oxidative stress by preincubation with conditioned media from 8-OH-DPAT-treated astrocytes. These protective effects were canceled by 5-HT1A antagonist or MT-1/-2-specific antibody. Furthermore, reduction of nigrostriatal dopaminergic neurons in 6-hydroxydopamine-lesioned parkinsonian model mice was significantly abrogated by repeated injections of 8-OH-DPAT. Treatment with 8-OH-DPAT markedly increased the expression of MT in striatal astrocytes in the hemi-parkinsonian mice. Our study provides a promising therapeutic strategy of neuroprotection against oxidative stress and progressive dopaminergic neurodegeneration by demonstrating the efficacy of targeting 5-HT1A receptors in astrocytes.",
keywords = "5-HT receptor, 8-OH-DPAT, Astrocyte, Metallothionein, Neuroprotection, Parkinson's disease",
author = "Ikuko Miyazaki and Masato Asanuma and Shinki Murakami and Mika Takeshima and Nao Torigoe and Yoshihisa Kitamura and Ko Miyoshi",
year = "2013",
month = "11",
doi = "10.1016/j.nbd.2013.08.003",
language = "English",
volume = "59",
pages = "244--256",
journal = "Neurobiology of Disease",
issn = "0969-9961",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Targeting 5-HT1A receptors in astrocytes to protect dopaminergic neurons in parkinsonian models

AU - Miyazaki, Ikuko

AU - Asanuma, Masato

AU - Murakami, Shinki

AU - Takeshima, Mika

AU - Torigoe, Nao

AU - Kitamura, Yoshihisa

AU - Miyoshi, Ko

PY - 2013/11

Y1 - 2013/11

N2 - Astrocytes are abundant neuron-supporting glial cells that harbor a powerful arsenal of neuroprotective antioxidative molecules and neurotrophic factors. Here we examined whether enrichment with healthy striatal astrocytes can provide neuroprotection against progressive dopaminergic neurodegeneration. Serotonin 1A (5-HT1A) agonist 8-OH-DPAT induced astrocyte proliferation and increased metallothionein-1/-2 (MT-1/-2), antioxidative molecules, in cultured astrocytes and the striatum of mice. Primary cultured mesencephalic dopamine neurons were protected against oxidative stress by preincubation with conditioned media from 8-OH-DPAT-treated astrocytes. These protective effects were canceled by 5-HT1A antagonist or MT-1/-2-specific antibody. Furthermore, reduction of nigrostriatal dopaminergic neurons in 6-hydroxydopamine-lesioned parkinsonian model mice was significantly abrogated by repeated injections of 8-OH-DPAT. Treatment with 8-OH-DPAT markedly increased the expression of MT in striatal astrocytes in the hemi-parkinsonian mice. Our study provides a promising therapeutic strategy of neuroprotection against oxidative stress and progressive dopaminergic neurodegeneration by demonstrating the efficacy of targeting 5-HT1A receptors in astrocytes.

AB - Astrocytes are abundant neuron-supporting glial cells that harbor a powerful arsenal of neuroprotective antioxidative molecules and neurotrophic factors. Here we examined whether enrichment with healthy striatal astrocytes can provide neuroprotection against progressive dopaminergic neurodegeneration. Serotonin 1A (5-HT1A) agonist 8-OH-DPAT induced astrocyte proliferation and increased metallothionein-1/-2 (MT-1/-2), antioxidative molecules, in cultured astrocytes and the striatum of mice. Primary cultured mesencephalic dopamine neurons were protected against oxidative stress by preincubation with conditioned media from 8-OH-DPAT-treated astrocytes. These protective effects were canceled by 5-HT1A antagonist or MT-1/-2-specific antibody. Furthermore, reduction of nigrostriatal dopaminergic neurons in 6-hydroxydopamine-lesioned parkinsonian model mice was significantly abrogated by repeated injections of 8-OH-DPAT. Treatment with 8-OH-DPAT markedly increased the expression of MT in striatal astrocytes in the hemi-parkinsonian mice. Our study provides a promising therapeutic strategy of neuroprotection against oxidative stress and progressive dopaminergic neurodegeneration by demonstrating the efficacy of targeting 5-HT1A receptors in astrocytes.

KW - 5-HT receptor

KW - 8-OH-DPAT

KW - Astrocyte

KW - Metallothionein

KW - Neuroprotection

KW - Parkinson's disease

UR - http://www.scopus.com/inward/record.url?scp=84883306197&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84883306197&partnerID=8YFLogxK

U2 - 10.1016/j.nbd.2013.08.003

DO - 10.1016/j.nbd.2013.08.003

M3 - Article

C2 - 23959140

AN - SCOPUS:84883306197

VL - 59

SP - 244

EP - 256

JO - Neurobiology of Disease

JF - Neurobiology of Disease

SN - 0969-9961

ER -